Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;5(1):e70080.
doi: 10.1002/cpz1.70080.

Genetically Engineered and Implantable Mouse Brain Tumor Models: Characterization by Immunohistochemistry and Flow Cytometry

Affiliations

Genetically Engineered and Implantable Mouse Brain Tumor Models: Characterization by Immunohistochemistry and Flow Cytometry

Apoorva Mirji et al. Curr Protoc. 2025 Jan.

Abstract

Gliomas are aggressive tumors with a poor prognosis. The protocols presented here outline the methods used to study tumor progression, the tumor microenvironment (TME), and the effects of experimental treatments. The Sleeping Beauty (SB) transposase system induces tumors de novo to generate mouse models that recapitulate human gliomas. Plasmids are constructed with oncogenic drivers and other genetic alterations of interest. which are recognized by their unique position in between inverted/direct repeat (IR/DR) sequences. Luciferase enzyme is used to monitor the uptake of the plasmid, tumor growth, and response to experimental therapies. The genes of interest are tracked using fluorescent markers. Tumors will arise in immunocompetent hosts, which provides a relevant preclinical platform for analysis of tumor initiation, progression, survival, immune microenvironment, and histopathological features. Once the tumor grows within the desired brain location, it can be harvested to generate cell cultures of neurospheres for future experimentation. The benefit of implantable models generated from SB tumors is that they provide specific anatomical and genetic context, in which specific genetic characteristics can be tracked, as they are co-expressed with fluorescent markers. Post glioma cell implantation, additional analysis of the TME and tumor growth can be performed through immunohistochemistry (IHC) and flow cytometry. © 2025 Wiley Periodicals LLC. Basic Protocol 1: Creation of mouse glioma models by Sleeping-Beauty-mediated transposition Basic Protocol 2: Generation of orthotopic implantable brain tumors and neurospheres Basic Protocol 3: Hematoxylin and eosin staining of glioma tissue samples Basic Protocol 4: Immunohistochemistry of glioma tissue samples Basic Protocol 5: Flow cytometry for immune cell analysis of the tumor microenvironment.

Keywords: Gliomas; flow cytometry; genetically engineered mouse models; immune microenvironment; immunohistochemistry; preclinical model.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

The authors declare no conflict of interest.

Similar articles

References

    1. B Garcia Fabiani M, Kadiyala P, R. Lowenstein P, & G. Castro M (2020). An optimized protocol for in vivo analysis of tumor cell division in a sleeping beauty-mediated mouse glioma model. V1. STAR Protocols. 10.17504/protocols.io.bf8hjrt6 - DOI - PMC - PubMed
    1. Calinescu A-A, Núñez FJ, Koschmann C, Kolb BL, Lowenstein PR, & Castro MG (2015). Transposon mediated integration of plasmid DNA into the subventricular zone of neonatal mice to generate novel models of glioblastoma. Journal of Visualized Experiments, (96). 10.3791/52443 - DOI - PMC - PubMed
    1. Nunez FM, Gauss JC, Mendez FM, Haase S, Lowenstein PR, & Castro MG (2020). Genetically engineered mouse model of brainstem high-grade glioma. STAR Protocols, 1(3), 100165. 10.1016/j.xpro.2020.100165 - DOI - PMC - PubMed
    1. Assi H, Candolfi M, Lowenstein PR, & Castro MG (n.d.). Rodent Glioma Models: Intracranial Stereotactic Allografts and Xenografts. essay. - PMC - PubMed
    1. Núñez FJ, Mendez FM, Kadiyala P, Alghamri MS, Savelieff MG, Garcia-Fabiani MB, Haase S, Koschmann C, Calinescu A-A, Kamran N, Saxena M, Patel R, Carney S, Guo MZ, Edwards M, Ljungman M, Qin T, Sartor MA, Tagett R, … Castro MG (2019). Idh1-R132h acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response. Science Translational Medicine, 11(479). 10.1126/scitranslmed.aaq1427 - DOI - PMC - PubMed

LinkOut - more resources